Grupo para la caracterización molecular de las neoplasias hematológicas
University of Rome Tor Vergata
Roma, ItaliaPublicaciones en colaboración con investigadores/as de University of Rome Tor Vergata (2)
2015
-
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: A matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Annals of Hematology, Vol. 94, Núm. 8, pp. 1347-1356
2004
-
Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial
Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092